Sort   by:  
 Page size 
UnknownSensitive ELISA-based detection method for the mitophagy marker p-S65-Ub in human cells, autopsy brain, and blood samples.
Not available
S-EPMC8496550 | biostudies-literature
UnknownAssociation between repeat sizes and clinical and pathological characteristics in carriers of C9ORF72 repeat expansions (Xpansize-72): a cross-sectional cohort study.
Not available
S-EPMC3879782 | biostudies-literature
UnknownGenome-wide association analysis identifies APOE as a mitophagy modifier in Lewy body disease.
Not available
S-EPMC12044520 | biostudies-literature
UnknownMultiple system atrophy and apolipoprotein E.
Not available
S-EPMC5889322 | biostudies-literature
UnknownProtective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants.
Not available
S-EPMC3829604 | biostudies-literature
UnknownHigher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC11872607 | biostudies-literature
UnknownHigher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10156147 | biostudies-literature
UnknownAssociation of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study.
Not available
S-EPMC3208320 | biostudies-literature
UnknownBaricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.
Not available
S-EPMC9333998 | biostudies-literature
UnknownEmpagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10957483 | biostudies-literature
Sort   by:  
 Page size